搜索
Mainz Biomed NV
MYNZ添加自选
0.844USD
0.0000.00%
收盘 07/01, 16:00（美东）报价延迟15分钟
35.06M总市值
亏损市盈率 TTM
关于 Mainz Biomed NV 公司
Mainz Biomed N.V. is a Germany based molecular genetics cancer diagnostic company. The Company operates under one segment, namely genetic diagnostic testing services. Its portfolio consists of various products and product candidates, such as ColoAlert, a colorectal cancer (CRC) screening stool-based DNA (deoxyribonucleic acid) test; PancAlert, a stool-based screening test for the detection of pancreatic cancer; GenoStrip, a platform technology to detect pathogens in environments on a molecular genetic basis. The Company competes with Exact Sciences, Epigenomics AG, Novigenix SA, GRAIL, Inc. and Agena Biosciences Inc.
Mainz Biomed NV简介
公司代码MYNZ
公司名称Mainz Biomed NV
上市日期Nov 04, 2021
CEOBaechler (Guido)
员工数量19
证券类型Ordinary Share
年结日Nov 04
公司地址Sirius Gutenberg Park
城市MAINZ
上市交易所NASDAQ OMX - NASDAQ BASIC
国家Germany
邮编55129
电话496131265140
网址https://www.mainzbiomed.com/
公司代码MYNZ
上市日期Nov 04, 2021
CEOBaechler (Guido)
Mainz Biomed NV公司高管
名称
名称/职务
职务
持股
持股变动
Dr. Heiner Dreismann, Ph.D.
Dr. Heiner Dreismann, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
64.50K
+96.59%
Mr. Hans Hekland
Mr. Hans Hekland
Non-Executive Independent Director
Non-Executive Independent Director
56.00K
+68.27%
Mr. Gregory J. (Greg) Tibbitts
Mr. Gregory J. (Greg) Tibbitts
Non-Executive Independent Director
Non-Executive Independent Director
55.88K
+17.90%
Mr. Guido Baechler
Mr. Guido Baechler
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
6.36K
-9410.50%
Dr. Chris von Toerne
Dr. Chris von Toerne
Chief Operating Officer
Chief Operating Officer
2.50K
+93.24%
Mr. William Caragol
Mr. William Caragol
Chief Financial Officer
Chief Financial Officer
--
--
名称
名称/职务
职务
持股
持股变动
Dr. Heiner Dreismann, Ph.D.
Dr. Heiner Dreismann, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
64.50K
+96.59%
Mr. Hans Hekland
Mr. Hans Hekland
Non-Executive Independent Director
Non-Executive Independent Director
56.00K
+68.27%
Mr. Gregory J. (Greg) Tibbitts
Mr. Gregory J. (Greg) Tibbitts
Non-Executive Independent Director
Non-Executive Independent Director
55.88K
+17.90%
Mr. Guido Baechler
Mr. Guido Baechler
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
6.36K
-9410.50%
Dr. Chris von Toerne
Dr. Chris von Toerne
Chief Operating Officer
Chief Operating Officer
2.50K
+93.24%
Mr. William Caragol
Mr. William Caragol
Chief Financial Officer
Chief Financial Officer
--
--
常见问题
Mainz Biomed NV的前五大股东是谁？
Mainz Biomed NV 的前五大股东如下：Dr. Heiner Dreismann, Ph.D.
有多少机构持有Mainz Biomed NV(MYNZ)的股份？
截至2026Q1，共有33家机构持有Mainz Biomed NV的股份，合计持有的股份价值约为1.23M，占公司总股份的9.84%。与2025Q4相比，机构持股有所增加，增幅为663009.00。